For people living with eosinophilic gastritis (EoG), keeping track of disease activity often requires repeated endoscopies and tissue biopsies. While these procedures provide valuable information, ...

Expert at Cincinnati Children's discusses how new pediatric-specific stents offer less invasive, adaptable treatment options ...

More than 80 local middle and high school students connected with Cincinnati Children's researchers and health professionals ...

A new clinical support tool called Anatool aims to provide point-of-care guidance to help healthcare professionals more consistently recognize and treat anaphylaxis, a severe and potentially ...

Cincinnati Children’s researchers link pediatric hospital admissions with local data on housing, parcel type, crime, evictions, neighborhood characteristics, and births to advance a more precise ...

More than 140 students participated in Cincinnati Children’s Discovery Day to explore research labs, meet scientists, and learn about careers in science and medicine. Cincinnati Children’s recently ...

Cincinnati Children’s will serve as one of an initial wave of 12 sites worldwide enrolling youth with autism into a long-term study designed to accelerate future therapeutic trials Cincinnati Children ...

“Confined culture system” developed at Cincinnati Children’s opens doors for faster, wider use of lab-grown human tissues in disease studies and drug development Thanks to special 3D-printed ...

Cerebral visual impairment (CVI) is now recognized as the leading cause of childhood bilateral low vision in developed countries. Despite this, it is often missed or diagnosed much later than it ...

Investigators from 49 research divisions at Cincinnati Children’s produced more than 4,000 peer-reviewed journal articles, book chapters, and other publications in FY2025. The following summaries ...

Combining three clinically used screening tools can accurately diagnose moderate to severe forms of cerebral palsy early, but typically misses milder cases, emphasizing the need for continued ...

Agreement calls for Cincinnati Children’s to work with New Zealand-based BioOra to test Alta-cel as treatment for relapsed or refractory B-ALL. Many adults with cancer are alive and thriving after ...